KIT and osteosarcoma: Adhikari et al. showed that CD117/Stro-1 double positive osteosarcoma cells possessed the stem cell-like properties of resistance to chemotherapeutic reagents, increased tumorigenicity, and increased capacity to metastasize in vivo [11].